Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MUSTANG BIO, INC. | Interim CFO | Common Stock | 0 | $0.52 | Apr 18, 2022 | Direct | |
TENAX THERAPEUTICS, INC. | Interim CFO | Common Stock | 0 | Oct 29, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MRKR | Marker Therapeutics, Inc. | Jun 30, 2023 | 0 | $0 | 3 | Jul 5, 2023 | Interim CFO |
SLGC | SomaLogic, Inc. | Jun 6, 2023 | 0 | $0 | 3 | Jun 15, 2023 | Interim CFO |
MBIO | MUSTANG BIO, INC. | Apr 18, 2022 | 0 | $0 | 3 | Jun 7, 2022 | Interim CFO |
TENX | TENAX THERAPEUTICS, INC. | Oct 29, 2021 | 0 | $0 | 3 | Nov 4, 2021 | Interim CFO |